Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial
CLEAR试验的事后分析:接受乐伐替尼联合帕博利珠单抗治疗的肾细胞癌患者与接受舒尼替尼治疗的肾细胞癌患者按基线转移情况划分的临床结局
期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.35288
Grünwald, Viktor; McKay, Rana R; Buchler, Tomas; Eto, Masatoshi; Park, Se Hoon; Takagi, Toshio; Zanetta, Sylvie; Keizman, Daniel; Suárez, Cristina; Négrier, Sylvie; Lee, Jae Lyun; Santini, Daniele; Bedke, Jens; Staehler, Michael; Kollmannsberger, Christian; Choueiri, Toni K; Motzer, Robert J; Burgents, Joseph E; Xie, Ran; Okpara, Chinyere E; Powles, Thomas